2/28/2020  5:30:53 PM Chg. -8.40 Volume Bid5:30:53 PM Ask5:30:53 PM Market Capitalization Dividend Y. P/E Ratio
269.20CHF -3.03% 41,857
Turnover: 9.8 mill.
266.00Bid Size: 30 274.00Ask Size: 100 3.17 bill.CHF 0.78% 44.72

Business description

Tecan Group AG is one of the leading global providers of laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics. The company specializes in the development, production and distribution of instruments and automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, forensic and diagnostic laboratories. As an original equipment manufacturer, Tecan is also one of the leaders in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries.

Management board & Supervisory board

Dr. Achim von Leoprechting
Management board
Dr. Rudolf Eugster, Andreas Wilhelm, Dr. Klaus Lun, Dr. Wael Yared, Erik Norström, Markus Schmid, Ralf Griebel (ab 1.05.2020), Ulrich Kanter
Supervisory board
Dr. Lukas Braunschweiler, Dr. Christa Kreuzburg, Dr. Daniel R. Marshak, Dr. Karen J. Huebscher, Dr. Oliver S. Fetzer, Heinrich Fischer, Lars Holmqvist

Company data

Name: Tecan Group AG
Address: Seestrasse 103,CH-8708 Männedorf
Phone: +41-44-922-8111
Fax: +41-44-922-8112
E-mail: info@tecan.com
Internet: www.tecan.com
Industry: Technology
Sector: Other Technology Industries
Sub sector: -
End of financial year: 12/31
Free Float: 45.33%
IPO date: -

Investor relations

Name: Martin Brändle
IR phone: +41-44-922-8430
IR Fax: +41-44-922-8889
IR e-mail: investor@tecan.com

Company calendar

CW 12 | 3/17/2020 4th Quarter/Annual Report
CW 15 | 4/7/2020 General Shareholder Meeting
CW 33 | 8/13/2020 Interim Report 2nd Quarter/6 Months

Main Shareholders

Chase Nominees Ltd., London
NN Groep N.V., Amsterdam (NL)
Massachusetts Mutual Life Insurance Company - Oppenheimer International Small - Mid Company Fund und OFIGTC International Small Cap Fund - Barings International Small Cap Equity
UBS Fund Management (Switzerland) AG, Basel (CH)
BlackRock, Inc.
APG Asset Management N.V.
T. Rowe Price Associates
Credit Suisse Funds AG